Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $12,600 | 1 | 74.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,444 | 2 | 20.4% |
| Consulting Fee | $650.00 | 1 | 3.9% |
| Unspecified | $158.67 | 1 | 0.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $12,600 | 1 | $0 (2024) |
| Celgene Corporation | $3,444 | 2 | $0 (2018) |
| Kite Pharma, Inc. | $650.00 | 1 | $0 (2019) |
| F. Hoffmann-La Roche AG | $158.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,759 | 2 | PFIZER INC. ($12,600) |
| 2019 | $650.00 | 1 | Kite Pharma, Inc. ($650.00) |
| 2018 | $2,866 | 1 | Celgene Corporation ($2,866) |
| 2017 | $578.00 | 1 | Celgene Corporation ($578.00) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $158.67 | Research |
| Study: LEO DLBCL R R | ||||||
| 06/05/2024 | PFIZER INC. | ADCETRIS (Biological) | Honoraria | Cash or cash equivalent | $12,600.00 | General |
| Category: Oncology | ||||||
| 11/18/2019 | Kite Pharma, Inc. | Yescarta (Drug) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: ONC | ||||||
| 01/19/2018 | Celgene Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,866.00 | General |
| 04/21/2017 | Celgene Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $578.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LEO DLBCL R R | F. Hoffmann-La Roche AG | $158.67 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 357 | 519 | $157,666 | $43,142 |
| 2022 | 7 | 277 | 485 | $139,151 | $39,494 |
| 2021 | 11 | 376 | 672 | $68,979 | $52,210 |
| 2020 | 9 | 306 | 529 | $55,340 | $39,785 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 190 | $54,773 | $16,952 | 30.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 144 | $39,888 | $8,707 | 21.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $15,075 | $4,152 | 27.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 42 | $15,372 | $3,808 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 53 | $10,017 | $3,561 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 22 | $9,790 | $2,932 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,664 | $1,837 | 27.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 18 | 18 | $4,932 | $884.85 | 17.9% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 11 | 11 | $1,155 | $307.78 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 146 | 228 | $66,120 | $21,392 | 32.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 133 | $35,644 | $7,392 | 20.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 37 | $13,098 | $2,963 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 39 | $7,371 | $2,539 | 34.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 17 | $7,565 | $2,412 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $6,633 | $1,933 | 29.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 20 | $2,720 | $862.38 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 158 | 246 | $32,332 | $23,609 | 73.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 50 | 223 | $15,773 | $12,607 | 79.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 44 | $4,422 | $3,590 | 81.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $3,663 | $2,602 | 71.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 17 | $3,051 | $2,332 | 76.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $2,982 | $2,287 | 76.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 32 | $2,905 | $2,138 | 73.6% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 19 | 19 | $1,595 | $1,159 | 72.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 23 | $1,291 | $1,003 | 77.7% |
About Dr. Thomas Habermann, M.D
Dr. Thomas Habermann, M.D is a Hematology healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790757672.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Habermann, M.D has received a total of $16,853 in payments from pharmaceutical and medical device companies, with $12,759 received in 2024. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Honoraria" ($12,600).
As a Medicare-enrolled provider, Habermann has provided services to 1,316 Medicare beneficiaries, totaling 2,205 services with total Medicare billing of $174,631. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Hematology
- Location Rochester, MN
- Active Since 02/03/2006
- Last Updated 08/14/2020
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1790757672
Products in Payments
- ADCETRIS (Biological) $12,600
- Yescarta (Drug) $650.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Rochester
Angela Dispenzieri, M.d, M.D
Hematology — Payments: $371,763
Stephen Ansell, M.d, M.D
Hematology — Payments: $297,187
Morie Gertz, M.d, M.D
Hematology — Payments: $285,858
Dr. Adrienne Victor, M.d, M.D
Hematology — Payments: $143,778
Thomas Witzig, M.d, M.D
Hematology — Payments: $110,341
Dr. Brea Lipe, M.d, M.D
Hematology — Payments: $87,225